All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel
.
Security |
Imputed Share Price |
Prev Shares |
Current Shares |
Change (Percent) |
Prev Value (USD x1000) |
Current Value (USD x1000) |
Change (Percent) |
VCEL / Vericel Corporation
|
|
|
|
|
|
|
|
SLGL / Sol-Gel Technologies Ltd.
|
|
|
|
|
|
|
|
GWP / GW Pharmaceuticals plc
|
|
|
|
|
|
|
|
IDRA / Idera Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
PRTK / Paratek Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
NUVA / Nuvasive Inc
|
|
|
|
|
|
|
|
US88165N2045 / Tetraphase Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
NTUS / Natus Medical Inc
|
|
|
|
|
|
|
|
PCRX / Pacira BioSciences, Inc.
|
|
|
|
|
|
|
|
MDWD / MediWound Ltd.
|
|
|
|
|
|
|
|
ANGO / AngioDynamics, Inc.
|
|
|
|
|
|
|
|
71426VAK4 / Pernix Therapeutics Holdings, Inc. Convertible Debt 4.25%
|
|
|
|
|
|
|
|
AGRX / Agile Therapeutics, Inc.
|
|
|
|
|
|
|
|
IVTY / Invuity, Inc.
|
|
|
|
|
|
|
|
BAX / Baxter International Inc.
|
|
|
|
|
|
|
|
VSCI /
|
|
|
|
|
|
|
|
VCYT / Veracyte, Inc.
|
|
|
|
|
|
|
|
GKOS / Glaukos Corporation
|
|
|
|
|
|
|
|
ATRS / Antares Pharma Inc
|
|
|
|
|
|
|
|
TPST / Tempest Therapeutics, Inc.
|
|
|
|
|
|
|
|
MDCO / Medicines Company
|
|
|
|
|
|
|
|
ADMS / Adamas Pharmaceuticals Inc
|
|
|
|
|
|
|
|
ESPR / Esperion Therapeutics, Inc.
|
|
|
|
|
|
|
|
US92220P1057 / Varian Medical Systems, Inc.
|
|
|
|
|
|
|
|
NVLN / NOVELION THERAPEUTICS INC.
|
|
|
|
|
|
|
|
CI / The Cigna Group
|
|
|
|
|
|
|
|
IART / Integra LifeSciences Holdings Corporation
|
|
|
|
|
|
|
|
PGNX / Progenics Pharmaceuticals, Inc. Call
|
|
|
|
|
|
|
|
NSTG / NanoString Technologies, Inc.
|
|
|
|
|
|
|
|
REPH / Societal CDMO Inc
|
|
|
|
|
|
|
|
LJPC / La Jolla Pharmaceutical Co.
|
|
|
|
|
|
|
|
ZGNX / Zogenix Inc
|
|
|
|
|
|
|
|
ANAB / AnaptysBio, Inc.
|
|
|
|
|
|
|
|
CORI / Corium International, Inc.
|
|
|
|
|
|
|
|
MRK / Merck & Co., Inc.
|
|
|
|
|
|
|
|
KALA / KALA BIO, Inc.
|
|
|
|
|
|
|
|
/ Oxford Immunotec Global PLC
|
|
|
|
|
|
|
|
PETX / Aratana Therapeutics, Inc.
|
|
|
|
|
|
|
|
451731103 / Ignyta, Inc.
|
|
|
|
|
|
|
|
ATEC / Alphatec Holdings, Inc.
|
|
|
|
|
|
|
|
IOVA / Iovance Biotherapeutics, Inc.
|
|
|
|
|
|
|
|
US00163U1060 / AMAG Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
SBBP / Strongbridge Biopharma plc
|
|
|
|
|
|
|
|
ADMA / ADMA Biologics, Inc.
|
|
|
|
|
|
|
|
NVTA / Invitae Corporation
|
|
|
|
|
|
|
|
TVTX / Travere Therapeutics, Inc.
|
|
|
|
|
|
|
|
RGLS / Regulus Therapeutics Inc.
|
|
|
|
|
|
|
|
SSKN / STRATA Skin Sciences, Inc.
|
|
|
|
|
|
|
|
ENDP / Endo International plc
|
|
|
|
|
|
|
|
CDTX / Cidara Therapeutics, Inc.
|
|
|
|
|
|
|
|
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
CFRX / ContraFect Corp
|
|
|
|
|
|
|
|
TLGT / Teligent Inc
|
|
|
|
|
|
|
|
AVDL / Avadel Pharmaceuticals plc
|
|
|
|
|
|
|
|
CPRX / Catalyst Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
TVTX / Travere Therapeutics, Inc. Call
|
|
|
|
|
|
|
|
SCYX / SCYNEXIS, Inc.
|
|
|
|
|
|
|
|
HZNP / Horizon Therapeutics Plc
|
|
|
|
|
|
|
|
HZNP / Horizon Therapeutics Plc Call
|
|
|
|
|
|
|
|
HRTX / Heron Therapeutics, Inc.
|
|
|
|
|
|
|
|
MRTX / Mirati Therapeutics, Inc.
|
|
|
|
|
|
|
|
BDSI / Biodelivery Sciences International
|
|
|
|
|
|
|
|